Overview

An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)

Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
This is a study of OZURDEX® use in clinical practice in patients with diabetic macular edema (DME).
Details
Lead Sponsor:
Allergan
Treatments:
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate